Skip to main content
. Author manuscript; available in PMC: 2024 May 14.
Published in final edited form as: J Addict Med. 2021 Jan-Feb;15(1):85–87. doi: 10.1097/ADM.0000000000000695

TABLE 1.

Toxicology Results Among Outpatients Seen for Routine Care in an Academic Medical Center in Boston, Massachusetts and Affiliated Primary Care Practices

Feb to July Period, Year 2014 2015 2016 2017 2018 2019
Total samples tested 1077 1326 1719 3012 4812 5357
BZE positive, n (%) 161 (14.9) 175 (13.2) 249 (14.5) 501 (16.6) 821 (17.1) 914 (17.1)
COC positive, n (%) 191 (17.7) 212 (16.0) 321 (18.7) 614 (20.4) 1139 (23.7) 1093 (20.4)
BZE or COC positive, n (%) 212 (19.7) 245 (18.5) 350 (20.4) 679 (22.5) 1198 (24.9) 1184 (22.1)
Fentanyl positive, n (%) TNP TNP TNP 282* (9.4) 665 (13.8) 839 (15.7)
6-MAM positive, n (%) 102 (9.5) 148 (11.2) 119 (6.9) 129 (4.3) 130 (2.7) 150 (2.8)
Methamphetamine positive, n (%) 10 (0.9) 13 (1.0) 20 (1.2) 79 (2.6) 106 (2.2) 272 (5.1)
Methamphetamine and BZE or COC positive, n (%) 1 (0.001) 3 (0.002) 6 (0.003) 34 (0.011) 48 (0.010) 119 (0.021)
Methamphetamine and fentanyl positive, n (%) TNP TNP TNP TNP 31 (0.006) 67 (0.013)
Methamphetamine and 6-MAM positive, n (%) 1 (0.001) 1 (0.0008) 3 (0.002) 9 (0.003) 5 (0.001) 7 (0.001)
*

Fentanyl testing started 3/6/17.

COC cutoff was 2.0 ng/ml until 2019 when it was changed to 4.0 ng/ml.

6-MAM, 6-monoacetylmorphine; BZE, Benzoylecgonine; COC, Cocaine; TNP, test not performed.